These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 26221582)
1. β-Elemene Inhibits Cell Proliferation by Regulating the Expression and Activity of Topoisomerases I and IIα in Human Hepatocarcinoma HepG-2 Cells. Gong M; Liu Y; Zhang J; Gao YJ; Zhai PP; Su X; Li X; Li Y; Hou L; Cui XN Biomed Res Int; 2015; 2015():153987. PubMed ID: 26221582 [TBL] [Abstract][Full Text] [Related]
2. Effects of cinobufacini injection on cell proliferation and the expression of topoisomerases in human HepG-2 hepatocellular carcinoma cells. Liu Y; Ban LY; Su X; Gao S; Liu JW; Cui XN Mol Med Rep; 2015 Jul; 12(1):1598-604. PubMed ID: 25815590 [TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of topoisomerase II alpha and evaluation of its effects on cell proliferation and apoptosis in glioblastoma cancer stem cells. Hong Y; Sang M; Shang C; Xue YX; Liu YH Neurosci Lett; 2012 Jun; 518(2):138-43. PubMed ID: 22569122 [TBL] [Abstract][Full Text] [Related]
4. Decreased topoisomerase IIα expression and altered histone and regulatory factors of topoisomerase IIα promoter in patients with chronic benzene poisoning. Yu K; Shi YF; Yang KY; Zhuang Y; Zhu RH; Xu X; Cai G Toxicol Lett; 2011 Jun; 203(2):111-7. PubMed ID: 21382456 [TBL] [Abstract][Full Text] [Related]
5. Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex. Huang L; Shitashige M; Satow R; Honda K; Ono M; Yun J; Tomida A; Tsuruo T; Hirohashi S; Yamada T Gastroenterology; 2007 Nov; 133(5):1569-78. PubMed ID: 17983804 [TBL] [Abstract][Full Text] [Related]
6. Fluorescein hydrazones as novel nonintercalative topoisomerase catalytic inhibitors with low DNA toxicity. Rahman AF; Park SE; Kadi AA; Kwon Y J Med Chem; 2014 Nov; 57(21):9139-51. PubMed ID: 25333701 [TBL] [Abstract][Full Text] [Related]
7. Modulation of topoisomerase IIα expression and chemosensitivity through targeted inhibition of NF-Y:DNA binding by a diamino p-anisyl-benzimidazole (Hx) polyamide. Pett L; Kiakos K; Satam V; Patil P; Laughlin-Toth S; Gregory M; Bowerman M; Olson K; Savagian M; Lee M; Lee M; Wilson WD; Hochhauser D; Hartley JA Biochim Biophys Acta Gene Regul Mech; 2017 May; 1860(5):617-629. PubMed ID: 27750031 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of topoisomerase IIalpha expression in advanced gallbladder carcinoma: a potential chemotherapeutic target. Washiro M; Ohtsuka M; Kimura F; Shimizu H; Yoshidome H; Sugimoto T; Seki N; Miyazaki M J Cancer Res Clin Oncol; 2008 Jul; 134(7):793-801. PubMed ID: 18204862 [TBL] [Abstract][Full Text] [Related]
9. DNA topoisomerase IIalpha and -beta expression in human ovarian cancer. Withoff S; van der Zee AG; de Jong S; Hollema H; Smit EF; Mulder NH; de Vries EG Br J Cancer; 1999 Feb; 79(5-6):748-53. PubMed ID: 10070864 [TBL] [Abstract][Full Text] [Related]
10. CS1 is a novel topoisomerase IIα inhibitor with favorable drug resistance profiles. Shen Y; Chen W; Zhao B; Hao H; Li Z; Lu C; Shen Y Biochem Biophys Res Commun; 2014 Oct; 453(3):302-8. PubMed ID: 25242524 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of topoisomerase IIalpha expression by transforming growth factor-beta1 is abrogated by the papillomavirus E7 protein. Satterwhite DJ; White RL; Matsunami N; Neufeld KL Cancer Res; 2000 Dec; 60(24):6989-94. PubMed ID: 11156401 [TBL] [Abstract][Full Text] [Related]
12. Glucose-regulated stresses cause degradation of DNA topoisomerase IIalpha by inducing nuclear proteasome during G1 cell cycle arrest in cancer cells. Kim HD; Tomida A; Ogiso Y; Tsuruo T J Cell Physiol; 1999 Jul; 180(1):97-104. PubMed ID: 10362022 [TBL] [Abstract][Full Text] [Related]
13. Oxocrebanine: A Novel Dual Topoisomerase inhibitor, Suppressed the Proliferation of Breast Cancer Cells MCF-7 by Inducing DNA Damage and Mitotic Arrest. Yu L; Han S; Lang L; Song H; Zhang C; Dong L; Jia S; Zhang Y; Xiao D; Liu J; Xu Y; Zhang X Phytomedicine; 2021 Apr; 84():153504. PubMed ID: 33611211 [TBL] [Abstract][Full Text] [Related]
14. A cysteine-reactive alkyl hydroquinone modifies topoisomerase IIα, enhances DNA breakage, and induces apoptosis in cancer cells. Lin TY; Huang CP; Au LC; Chang YW; Hu CY; Lin SB Chem Res Toxicol; 2012 Nov; 25(11):2340-51. PubMed ID: 23088786 [TBL] [Abstract][Full Text] [Related]
15. (-)-Menthol inhibits DNA topoisomerases I, II alpha and beta and promotes NF-kappaB expression in human gastric cancer SNU-5 cells. Lin JP; Lu HF; Lee JH; Lin JG; Hsia TC; Wu LT; Chung JG Anticancer Res; 2005; 25(3B):2069-74. PubMed ID: 16158947 [TBL] [Abstract][Full Text] [Related]
16. DNA topoisomerase II-alpha as a proliferation marker in human gliomas: correlation with PCNA expression and patient survival. Zhao H; Yu H; Liu Y; Wang Y; Cai W Clin Neuropathol; 2008; 27(2):83-90. PubMed ID: 18402387 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of Lewis(y) antigen protects ovarian cancer RMG-1 cells from carboplatin-induced apoptosis by the upregulation of Topo-I and Topo-II β. Wang C; Yan L; Wang Y; Lin B; Liu S; Li Q; Gao L; Zhang S; Iwamori M Anat Rec (Hoboken); 2011 Jun; 294(6):961-9. PubMed ID: 21542140 [TBL] [Abstract][Full Text] [Related]
18. HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase IIalpha. Stros M; Polanská E; Struncová S; Pospísilová S Nucleic Acids Res; 2009 Apr; 37(7):2070-86. PubMed ID: 19223331 [TBL] [Abstract][Full Text] [Related]
19. Fluorescein hydrazones: A series of novel non-intercalative topoisomerase IIα catalytic inhibitors induce G1 arrest and apoptosis in breast and colon cancer cells. Islam MS; Park S; Song C; Kadi AA; Kwon Y; Rahman AF Eur J Med Chem; 2017 Jan; 125():49-67. PubMed ID: 27654394 [TBL] [Abstract][Full Text] [Related]
20. Modulation of topoisomerase IIalpha expression by a DNA sequence-specific polyamide. Hochhauser D; Kotecha M; O'hare C; Morris PJ; Hartley JM; Taherbhai Z; Harris D; Forni C; Mantovani R; Lee M; Hartley JA Mol Cancer Ther; 2007 Jan; 6(1):346-54. PubMed ID: 17237293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]